CardioDx strikes deal to bring artery disease assay to India

04/26/2013 | GenomeWeb Daily News (free registration)

CardioDx has agreed to allow Core Diagnostics India to distribute its Corus CAD diagnostic system in India for undisclosed terms. The blood-based gene expression test, which was released as a laboratory-developed assay in 2009, is intended to screen patients showing symptoms of obstructive coronary artery disease.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC